News
Astellas paves backloaded biobucks deal to test 4DMT's eye disease gene therapy vector. By Annalee Armstrong Jul 10, 2023 7:30pm. Astellas Pharma 4D Molecular Therapeutics eye ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback